{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T16:27:52Z","timestamp":1789921672256,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[1992,5]]},"DOI":"10.1007\/bf00124252","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T17:06:58Z","timestamp":1099415218000},"page":"199-205","source":"Crossref","is-referenced-by-count":28,"title":["Oral contraceptive use and risk of cutaneous malignant melanoma in a case-control study of French women"],"prefix":"10.1007","volume":"3","author":[{"given":"M. G.","family":"L\ufffd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Cabanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Desvignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Chanteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mlika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/jid.1960.87","volume":"35","author":"RS Snell","year":"1960","unstructured":"Snell RS, Bischitz PG. The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol 1960; 35: 73?82.","journal-title":"J Invest Dermatol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0140-6736(76)92592-7","volume":"2","author":"RI Fisher","year":"1976","unstructured":"Fisher RI, Neifeld JP, Lippman ME. Estrogen receptors in human malignant melanoma. Lancet 1976; 2: 337?8.","journal-title":"Lancet"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/1097-0142(19801015)46:8<1785::AID-CNCR2820460815>3.0.CO;2-0","volume":"46","author":"ET Creagan","year":"1980","unstructured":"Creagan ET, Ingle JN, Woods JE, Pritchard DJ, Jiang NS. Estrogen receptors in patients with malignant melanoma. Cancer 1980; 46: 1785?6.","journal-title":"Cancer"},{"key":"CR4","first-page":"39","volume":"33","author":"MF Avril","year":"1985","unstructured":"Avril MF, Delarue JC, Prade M. R\u00e9cepteurs oestrog\u00e9niques et progest\u00e9roniques dans les m\u00e9lanomes malins, les naevi pigmentaires b\u00e9nins et les \u00e9pith\u00e9liomas basocellulaires. Pathol Biol 1985; 33: 39?44.","journal-title":"Pathol Biol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archderm.1987.01660300086017","volume":"123","author":"J Flowers","year":"1987","unstructured":"Flowers J, Seigler H, MacCarty K Sr, Konrath J, MacCarty KJr. Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody. Arch Dermatol 1987; 123: 764?5.","journal-title":"Arch Dermatol"},{"key":"CR6","first-page":"819","volume":"64","author":"CP Karakousis","year":"1980","unstructured":"Karakousis CP, Lopez RE, Bhakoo HS, Rosen F, Hoore R, Carlson M. Estrogen and progesterone receptors and Tamoxifen in malignant melanoma. Cancer Treat Rep 1980; 64: 819?27.","journal-title":"Cancer Treat Rep"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/bjc.1977.265","volume":"36","author":"V Beral","year":"1977","unstructured":"Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977; 36: 804?9.","journal-title":"Br J Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/bjc.1981.145","volume":"44","author":"SA Adam","year":"1981","unstructured":"Adam SA, Sheaves JK, Wright NH, Mosser RW, Vessey MP. A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 1981; 44: 45?50.","journal-title":"Br J Cancer"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/bjc.1981.211","volume":"44","author":"CR Kay","year":"1981","unstructured":"Kay CR. Malignant melanoma and oral contraceptive (Letter). Br J Cancer 1981; 44: 479.","journal-title":"Br J Cancer"},{"key":"CR10","first-page":"537","volume":"68","author":"C Bain","year":"1982","unstructured":"Bain C, Hennekens CH, Speizer FE, Rosner B, Willett W, Belanger C. Oral contraceptive use and malignant melanoma. JNCI 1982; 68: 537?9.","journal-title":"JNCI"},{"key":"CR11","first-page":"827","volume":"70","author":"EA Holly","year":"1983","unstructured":"Holly EA, Weiss NS, Liff JM. Cutaneous melanoma in relation to exogenous hormones and reproductives factors. JNCI 1983, 70: 827?31.","journal-title":"JNCI"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/bjc.1984.236","volume":"50","author":"V Beral","year":"1984","unstructured":"Beral V, Evans S, Shaw H, Milton G. Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 1984; 50: 681?5.","journal-title":"Br J Cancer"},{"key":"CR13","first-page":"617","volume":"72","author":"SP Helmrich","year":"1984","unstructured":"Helmrich SP, Rosenberg L, Kaufman DW, et al. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. JNCI 1984; 72: 617?20.","journal-title":"JNCI"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bjc.1984.235","volume":"50","author":"CDJ Holman","year":"1984","unstructured":"Holman CDJ, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50: 673?80.","journal-title":"Br J Cancer"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/bjc.1985.275","volume":"52","author":"RP Gallagher","year":"1985","unstructured":"Gallagher RP, Ellwood JM, Hill CB, Coldman AJ, Threlfall WJ, Spinelli JJ. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 1985; 52: 901?7.","journal-title":"Br J Cancer"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ijc.2910420603","volume":"42","author":"A Osterlind","year":"1988","unstructured":"Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 1988; 42: 821?4.","journal-title":"Int J Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/oxfordjournals.aje.a112623","volume":"108","author":"NE Breslow","year":"1978","unstructured":"Breslow NE, Day NE, Halvorsen DT, Prentice RL, Sabai C. Estimation of multiple relative risk function in matched case control study. Am J Epidemiol 1978; 108: 299?306.","journal-title":"Am J Epidemiol"},{"key":"CR18","series-title":"IARC Sci. Pub.","volume-title":"Statistical methods in cancer research","author":"NE Breslow","year":"1980","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Breslow NE and Day NE Eds. Lyon, France: International Agency for Research on Cancers, 1980. IARC Sci. Pub. No. 32."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","volume":"129","author":"RM Mickey","year":"1989","unstructured":"Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125?37.","journal-title":"Am J Epidemiol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2105\/AJPH.68.4.335","volume":"68","author":"R Hoover","year":"1978","unstructured":"Hoover R, Bain C, Cole P, MacMahon B. Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. Am J Public Health 1978; 68: 335?41.","journal-title":"Am J Public Health"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/978-3-642-82641-2_8","volume":"102","author":"EA Holly","year":"1986","unstructured":"Holly EA. Current issues in melanoma research: exogenous hormones, pregnancy. Recent Results in Cancer Res 1986; 102: 108?17.","journal-title":"Recent Results in Cancer Res"}],"container-title":["Cancer Causes and Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00124252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00124252\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00124252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T09:17:34Z","timestamp":1554283054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00124252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["BF00124252"],"URL":"https:\/\/doi.org\/10.1007\/bf00124252","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}